What The Evidence and Risk Factors Say Wegovy does not directly fuel Candida like antibiotics or immunosuppression can, and controlled trials have not linked it to an apparent surge in yeast infection rates
Men on GLP-1 therapy or men concerned about collagen and connective tissue support have no ingredient-level reason not to consider this product
Starting with the recommendations on Discussing Obesity Medications, Select obesity medications using a person-centered approach that incorporates shared decision-making and is grounded in the best available evidence
Best Approach for Some: Combine GLP-1s and Bariatric Surgery For some people, the best approach to weight loss may be a combination of GLP-1s and weight loss surgery
Tissot, Lausanne (Hmatologie)
47 Another review of Phase III clinical trials reported similar findings and noted that of the long-acting formulations, once-weekly exenatide was shown to cause a greater number of injection-site reactions compared to once-weekly semaglutide and dulaglutide